Nicox

en fr

About Us
Pipeline, Markets and Science
Investors
News and Events
Contact Us

Nicox’s NCX 4251 Mississippi Phase 2b Blepharitis Trial Reaches 50% Enrollment

April 23, 2021

← Back to blog page

Nicox

Contact Us
Subscribe to news
Legal Notice

Search

© Copyright Nicox, all rights reserved

Cookies

By continuing to use this website, you agree to our Cookie Policy.